Single User License
INR 96975
Site License
INR 193950
Corporate User License
INR 290925

Service Tax Additional

select a format

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

GeoVax Labs, Inc.-Product Pipeline Review-2015

GeoVax Labs, Inc.-Product Pipeline Review-2015

  • Products Id :- GMDHC07284CDB
  • |
  • Pages: 37
  • |
  • July 2015
  • |
  • |
  Request for Sample Report

Executive Summary

GeoVax Labs, Inc.-Product Pipeline Review-2015


Global Markets Direct's, 'GeoVax Labs, Inc.-Product Pipeline Review-2015', provides an overview of the GeoVax Labs, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of GeoVax Labs, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of GeoVax Labs, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of GeoVax Labs, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the GeoVax Labs, Inc.'s pipeline products

Reasons To Buy

Evaluate GeoVax Labs, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of GeoVax Labs, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the GeoVax Labs, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of GeoVax Labs, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of GeoVax Labs, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of GeoVax Labs, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

GeoVax Labs, Inc. Snapshot 5

GeoVax Labs, Inc. Overview 5

Key Information 5

Key Facts 5

GeoVax Labs, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

GeoVax Labs, Inc.-Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products-Monotherapy 9

GeoVax Labs, Inc.-Pipeline Products Glance 10

GeoVax Labs, Inc.-Clinical Stage Pipeline Products 10

Phase II Products/Combination Treatment Modalities 10

GeoVax Labs, Inc.-Early Stage Pipeline Products 11

Preclinical Products/Combination Treatment Modalities 11

GeoVax Labs, Inc.-Drug Profiles 12

GOVXB-11 12

Product Description 12

Mechanism of Action 12

R&D Progress 12


Product Description 14

Mechanism of Action 14

R&D Progress 14


Product Description 16

Mechanism of Action 16

R&D Progress 16

GOVXC-11 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

GOVXC-21 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

GOVXE-301 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

GOVXE-302 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

GeoVax Labs, Inc.-Pipeline Analysis 21

GeoVax Labs, Inc.-Pipeline Products by Target 21

GeoVax Labs, Inc.-Pipeline Products by Route of Administration 22

GeoVax Labs, Inc.-Pipeline Products by Molecule Type 23

GeoVax Labs, Inc.-Recent Pipeline Updates 24

GeoVax Labs, Inc.-Dormant Projects 27

GeoVax Labs, Inc.-Company Statement 28

GeoVax Labs, Inc.-Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Appendix 36

Methodology 36

Coverage 36

Secondary Research 36

Primary Research 36

Expert Panel Validation 36

Contact Us 36

Disclaimer 37

List of Tables

GeoVax Labs, Inc., Key Information 5

GeoVax Labs, Inc., Key Facts 5

GeoVax Labs, Inc.-Pipeline by Indication, 2015 7

GeoVax Labs, Inc.-Pipeline by Stage of Development, 2015 8

GeoVax Labs, Inc.-Monotherapy Products in Pipeline, 2015 9

GeoVax Labs, Inc.-Phase II, 2015 10

GeoVax Labs, Inc.-Preclinical, 2015 11

GeoVax Labs, Inc.-Pipeline by Target, 2015 21

GeoVax Labs, Inc.-Pipeline by Route of Administration, 2015 22

GeoVax Labs, Inc.-Pipeline by Molecule Type, 2015 23

GeoVax Labs, Inc.-Recent Pipeline Updates, 2015 24

GeoVax Labs, Inc.-Dormant Developmental Projects,2015 27

GeoVax Labs, Inc., Subsidiaries 35

List of Figures

GeoVax Labs, Inc.-Pipeline by Top 10 Indication, 2015 7

GeoVax Labs, Inc.-Pipeline by Stage of Development, 2015 8

GeoVax Labs, Inc.-Monotherapy Products in Pipeline, 2015 9

GeoVax Labs, Inc.-Pipeline by Top 10 Target, 2015 21

GeoVax Labs, Inc.-Pipeline by Top 10 Molecule Type, 2015 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Current R&D Portfolio of GeoVax Labs, Inc.; GeoVax Labs, Inc. - Key Therapeutics; GeoVax Labs, Inc. - Pipeline Overview and Promising Molecules; GeoVax Labs, Inc. - News; GeoVax Labs, Inc. - Latest Updates; GeoVax Labs, Inc. - Pipeline; GeoVax Labs, Inc. - Discontinued/Dormant Projects

Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]